Medical Diagnostics Market by Type, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Nov 2022 Pages: 171 SKU: IRTNTR71046

Medical Diagnostics Market Analysis Report 2023-2027:

The medical diagnostics market size is estimated to grow at a CAGR of 6.15% between 2022 and 2027. The size of the market is forecast to increase by USD 74.58 billion. The growth of the market depends on several factors, including the high prevalence of infectious diseases, the growing geriatric population, and the demand for personalized medicine.

This report extensively covers market segmentation by type (IVD and diagnostic imaging), end-user (hospitals and clinics, diagnostic centers, research laboratories and institutes, and others), and geography (North America, Asia, Europe, and the Rest of the World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

 What will the Size of the Medical Diagnostics Market be During the Forecast Period?

To learn more about this report,  Download Medical Diagnostics Market Research Report Sample PDF

Medical Diagnostics Market: Key Drivers, Trends, Challenges, and Customer Landscape

The high prevalence of infectious diseases is notably driving the market growth, although factors such as the lack of trained laboratory technicians may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Medical Diagnostics Market Driver 

The high prevalence of infectious diseases is notably driving the medical diagnostics market growth. The high prevalence of infectious diseases such as influenza A, malaria, dengue, and human immunodeficiency virus (HIV) and the outbreak of the COVID-19 pandemic have driven the demand for medical diagnostics worldwide. Infectious diseases such as Hepatitis B, Hepatitis C, HIV, Herpes, and COVID-19 caused by viruses require various diagnostic tests for treatment.

Molecular diagnostic techniques like enzyme-linked immunosorbent assay (ELISA) help in the early detection of infections through antigen and antibody interactions to prevent disease progression. Thus, changing global demographics, such as the ageing population and high incidence rates of infectious diseases, contribute to the growth of the market. Therefore, the increasing prevalence of infectious diseases will augment the demand for medical diagnostics during the forecast period.

Key Medical Diagnostics Market Trends

The global adoption of advanced diagnostic solutions is the key trend driving the medical diagnostics market growth. The availability of advanced treatment enables increased adoption rates among healthcare providers. The use and adoption of in-vitro diagnostics to manage and test for cancer, CVDs, and infectious kidney diseases along with immunoassay and molecular diagnostic devices are increasing. For instance, the Xprecia Stride Coagulation Analyzer from Siemens is a handheld device that performs ProTime INR (PT/INR) tests with high accuracy. This growth of specialty testing in the fields of esoteric, pathology, and genetic testing is projected to rise during the forecast period.

The increased need for diagnostic products also encourages companies to focus on providing customized automation solutions to address the needs of patients. For instance, Atellica Solution is a next-generation immunoassay and clinical chemistry analyzer from Siemens. It is flexible, and efficient, and provides more than 300 customizable configurations to diagnose diseases. Furthermore, the adoption of point-of-care testing (POCT) is rising globally due to its efficient workflow process and advantages like the ability to be performed at the bedside, portability, and timely and rapid diagnosis. These factors will drive the growth of the market during the forecast period.

Key Medical Diagnostics Market Challenge

The lack of trained laboratory technicians is the major challenge impeding the market growth. Most critical diagnostic tests like clinical chemistry, immunoassays, and molecular diagnostics require trained professionals with high dexterity and skills to handle tools and accurately perform the techniques. However, the market lacks trained laboratory technicians to handle these devices. Lack of expertise increases the probability of misdiagnosis. The major factors responsible for this shortfall are the immigration of well-established trained specialists from developing countries to developed countries, a lack of standardization and prescribed curriculum knowledge on techniques, and the lack of proper training in handling devices. In addition, the need for expensive and multi-year theoretical studies to become qualified professionals or technicians also contributes to the shortage of trained laboratory technicians. Experience and skills in handling and using diagnostic tools play a major role in the early diagnosis and treatment of diseases. 

The market also has a shortage of trained professionals who can handle technologically advanced diagnostic devices. In automated handling systems, incorrect data input can hamper the outcome of tests, which may affect the diagnosis. Therefore, it is important to educate staff on the use of critical diagnostic devices. Trained professionals must handle automated handling systems, as accuracy and reliability play a vital role in diagnostic laboratories. Hence, the limited availability of trained laboratory staff can negatively affect the market's growth during the forecast period.

Key Medical Diagnostics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Medical Diagnostics Market Customer Landscape

Who are the Major Medical Diagnostics Market Vendors?                                     

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - Under the diagnostics segment, the company offers medical diagnostics for cancer, cardiac, and infectious diseases as its key offering. Under this segment, the company also focuses on core laboratory, molecular solutions, point-of-care solutions, and rapid diagnostics. Additionally, under its medical device segment, the company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. 

The market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • 3M Co.
  • Agilent Technologies Inc.
  • Becton Dickinson & Co.
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Charles River Laboratories
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • General Electric Co.
  • Hologic Inc.
  • Medtronic Plc
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Quidel Corp.

A qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Medical Diagnostics Market?

The market share growth by the IVD segment will be significant during the forecast period.  The importance of the IVD segment is increasing because of the growing need for improved real-time diagnostic tools for the early diagnosis of communicable and chronic diseases. The market is driven by factors such as the inclusion of advanced technology such as genetic testing, molecular diagnostics, epigenomics-based diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS), which offer rapid turnaround time and advantages like reliability, user-friendliness, and predictability of specific disease conditions. 

Get a glance at the market contribution of various segments  Request Market Research Report Sample PDF

The IVD segment showed a gradual increase in market share with USD 93.58 billion in 2017 and will continue to grow by 2021. The introduction of molecular diagnostics has accelerated the growth of the market because of benefits like detecting specific deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequences to diagnose diseases at a rapid rate. This technology is mostly used for blood and infectious disease-screening applications. The development of personalized medicine using this technology is gaining momentum due to the advantage of detecting small infectious molecules. The demand for live-cell imaging products is increasing among end-users because of their benefits, thereby fueling the growth of the market during the forecast period. 

Which are the Key Regions for the Medical Diagnostics Market?

For more insights on the market share of various regions Request PDF Sample now!

Asia is projected to contribute 38% by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The medical diagnostics market in North America had a considerable market share in 2020. The US was the largest contributor to the regional market due to increased insurance coverage, rise in R&D expenditure, rise in geriatric population with chronic diseases, high healthcare spending, and increase in promotions about the use of POC tests for the early detection of diseases. The presence of many vendors offering medical diagnostics in the US is also contributing to the market's growth. The increasing prevalence of chronic diseases and the growing adoption of imaging procedures influence vendors to employ various market strategies, such as product launches and partnerships with distributors, further strengthening their market presence.

By January 2021, lockdown restrictions in various countries were relaxed, which helped in the resumption of business activities. The demand for antibody tests and blood tests will increase even after the containment of the COVID-19 pandemic to check the health conditions of people with symptoms of 'long COVID-19' and others. Moreover, the resumption of various preclinical studies and pharmaceutical operations will drive the demand for medical diagnostics in North America during the forecast period.

Segment Overview

The medical diagnostics report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by type, end-user, and region.

  • Type Outlook ( USD Billion, 2017 - 2027)
    • IVD
    • Diagnostic imaging
  • End-user Outlook ( USD Billion, 2017 - 2027)
    • Hospitals and clinics
    • Diagnostic centers
    • Research laboratories and institutes
    • Others
  • Region Outlook ( USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Asia
      • China
      • India
      • Singapore
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Medical Diagnostics Market Scope

Report Coverage

Details

Page number

171

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.15%

Market growth 2023-2027

USD 74.58 billion

Market structure

Fragmented

YoY growth (%)

5.69

Regional analysis

North America, Asia, Europe, and the Rest of the World (ROW)

Performing market contribution

Asia at 38%

Key countries

US, China, Japan, Germany, and UK

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

3M Co., Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., General Electric Co., Hologic Inc., Medtronic Plc, QIAGEN NV, Quest Diagnostics Inc., Quidel Corp., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Market Research Report Sample PDF

What are the Key Data Covered in this Medical Diagnostics Market Research Report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the medical diagnostics market size and its contribution to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behaviour.
  • Growth of the industry across North America, Asia, Europe, and the Rest of the World (ROW).
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of medical diagnostics market vendors.

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global medical diagnostics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global medical diagnostics market 2017 - 2021 ($ billion)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 IVD - Market size and forecast 2022-2027
      • Exhibit 34: Chart on IVD - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on IVD - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on IVD - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on IVD - Year-over-year growth 2022-2027 (%)
    • 6.4 Diagnostic imaging - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Diagnostic imaging - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Diagnostic imaging - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Diagnostic imaging - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Diagnostic imaging - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 45: Chart on Comparison by End-user
      • Exhibit 46: Data Table on Comparison by End-user
    • 7.3 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 7.4 Diagnostic centers - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 52: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
    • 7.5 Research laboratories and institutes - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 56: Data Table on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Chart on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by End-user
      • Exhibit 63: Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 67: Chart on Geographic comparison
      • Exhibit 68: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Japan - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 105: Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 108: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 109: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 110: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 111: Matrix on vendor position and classification
            • 12.3 3M Co.
              • Exhibit 112: 3M Co. - Overview
              • Exhibit 113: 3M Co. - Business segments
              • Exhibit 114: 3M Co. - Key news
              • Exhibit 115: 3M Co. - Key offerings
              • Exhibit 116: 3M Co. - Segment focus
            • 12.4 Abbott Laboratories
              • Exhibit 117: Abbott Laboratories - Overview
              • Exhibit 118: Abbott Laboratories - Business segments
              • Exhibit 119: Abbott Laboratories - Key news
              • Exhibit 120: Abbott Laboratories - Key offerings
              • Exhibit 121: Abbott Laboratories - Segment focus
            • 12.5 Agilent Technologies Inc.
              • Exhibit 122: Agilent Technologies Inc. - Overview
              • Exhibit 123: Agilent Technologies Inc. - Business segments
              • Exhibit 124: Agilent Technologies Inc. - Key news
              • Exhibit 125: Agilent Technologies Inc. - Key offerings
              • Exhibit 126: Agilent Technologies Inc. - Segment focus
            • 12.6 Bio Rad Laboratories Inc.
              • Exhibit 127: Bio Rad Laboratories Inc. - Overview
              • Exhibit 128: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 129: Bio Rad Laboratories Inc. - Key news
              • Exhibit 130: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 131: Bio Rad Laboratories Inc. - Segment focus
            • 12.7 bioMerieux SA
              • Exhibit 132: bioMerieux SA - Overview
              • Exhibit 133: bioMerieux SA - Product / Service
              • Exhibit 134: bioMerieux SA - Key offerings
            • 12.8 Charles River Laboratories
              • Exhibit 135: Charles River Laboratories - Overview
              • Exhibit 136: Charles River Laboratories - Business segments
              • Exhibit 137: Charles River Laboratories - Key news
              • Exhibit 138: Charles River Laboratories - Key offerings
              • Exhibit 139: Charles River Laboratories - Segment focus
            • 12.9 Danaher Corp.
              • Exhibit 140: Danaher Corp. - Overview
              • Exhibit 141: Danaher Corp. - Business segments
              • Exhibit 142: Danaher Corp. - Key news
              • Exhibit 143: Danaher Corp. - Key offerings
              • Exhibit 144: Danaher Corp. - Segment focus
            • 12.10 DiaSorin SpA
              • Exhibit 145: DiaSorin SpA - Overview
              • Exhibit 146: DiaSorin SpA - Business segments
              • Exhibit 147: DiaSorin SpA - Key news
              • Exhibit 148: DiaSorin SpA - Key offerings
              • Exhibit 149: DiaSorin SpA - Segment focus
            • 12.11 F. Hoffmann La Roche Ltd.
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.12 General Electric Co.
              • Exhibit 155: General Electric Co. - Overview
              • Exhibit 156: General Electric Co. - Business segments
              • Exhibit 157: General Electric Co. - Key news
              • Exhibit 158: General Electric Co. - Key offerings
              • Exhibit 159: General Electric Co. - Segment focus
            • 12.13 Hologic Inc.
              • Exhibit 160: Hologic Inc. - Overview
              • Exhibit 161: Hologic Inc. - Business segments
              • Exhibit 162: Hologic Inc. - Key news
              • Exhibit 163: Hologic Inc. - Key offerings
              • Exhibit 164: Hologic Inc. - Segment focus
            • 12.14 QIAGEN NV
              • Exhibit 165: QIAGEN NV - Overview
              • Exhibit 166: QIAGEN NV - Product / Service
              • Exhibit 167: QIAGEN NV - Key news
              • Exhibit 168: QIAGEN NV - Key offerings
            • 12.15 Quest Diagnostics Inc.
              • Exhibit 169: Quest Diagnostics Inc. - Overview
              • Exhibit 170: Quest Diagnostics Inc. - Business segments
              • Exhibit 171: Quest Diagnostics Inc. - Key offerings
              • Exhibit 172: Quest Diagnostics Inc. - Segment focus
            • 12.16 Siemens AG
              • Exhibit 173: Siemens AG - Overview
              • Exhibit 174: Siemens AG - Business segments
              • Exhibit 175: Siemens AG - Key news
              • Exhibit 176: Siemens AG - Key offerings
              • Exhibit 177: Siemens AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 178: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 179: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 180: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 181: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 182: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 183: Inclusions checklist
                • Exhibit 184: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 185: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 186: Research methodology
                • Exhibit 187: Validation techniques employed for market sizing
                • Exhibit 188: Information sources
              • 13.5 List of abbreviations
                • Exhibit 189: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              medical diagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis